“…Enzymes, as crucial biocatalysts, are omnipresent in living organisms and actively participate in diverse physiological regulatory processes for maintaining normal bodily functions. , The physiological functionalities of enzymes in vivo are intricately intertwined with their expression levels, and abnormal enzyme activities generally serve as a pivotal indicator for clinical diagnosis of various diseases. , Among these crucial enzymes, alkaline phosphatase (ALP) functions as a hydrolase to facilitate the dephosphorylation of proteins, nucleic acids, and other biomolecules . Meanwhile, butyryl cholinesterase (BChE) is involved in nonspecific hydrolysis reactions encompassing both cholinesterase and noncholinesterase compounds . The ALP and BChE biomarkers have been clinically recognized as crucial indicators for the identification of liver disorders, including cirrhosis, hepatic impairment, and chronic hepatitis. , Moreover, aberrant ALP and BChE levels in the bloodstream have been closely associated with diabetes, hypertension, hyperthyroidism, and malignant tumors. , Therefore, the simultaneous, facile, and accurate determination of ALP and BChE activities in blood is of paramount significance and urgency for the early diagnosis and prognosis of the associated diseases.…”